Someone tipped me off to ALLO, which took a tumble on Friday as the FDA put a hold on their trial treatment, and I'm just starting to look into it. Apparently there was a negative response in one of their trial participants. I'd be really interested in hearing from any of the ccxi chevra who want to take a look and share thoughts. The opportunity I see here is that the hold could be lifted if the incident can be pinned on a different underlying cause, and the company has almost 50% of the current market cap in cash.